Field Notes From Inner Space: Global Psychedelic Survey Participants Report Health Benefits, Personal Growth, and Life Transformations
J. Robinson, Noah Wallace, Esenia K. Cassidy, Stephanie Lake, Philippe Lucas
Contemporary Drug Problems April 25, 2026 DOI: 10.1177/00914509261444382 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Qualitative study Peer reviewed |
|---|---|
| Key findings | Identifies three common themes in psychedelic user narratives: perceived therapeutic outcomes, enhanced psychological wellbeing and personal development, and profound shifts in life perspective and meaning, alongside accounts of potential risks. |
Abstract
Psychedelics are being used globally in a variety of contexts, from recreational use to controlled clinical trials of therapeutic applications. Much of what is known about psychedelic user experiences comes from quantitative studies, while qualitative research is limited and has received comparatively less attention. Qualitative research, particularly personal narratives, can highlight the nuanced impact users have experienced, which quantitative research may be unable to capture. The present study is an exploratory analysis of qualitative responses from the Global Psychedelic Survey 2023, aimed at addressing the gap between quantitative and qualitative literature in naturalistic psychedelic use. Using inductive thematic analysis, three common themes in participants’ accounts of their psychedelic experiences were identified: perceived therapeutic outcomes, enhanced psychological wellbeing and personal development, and profound shifts in life perspective and meaning. Such narratives bring forth detailed accounts of the impact psychedelic users have experienced, as well as potential risks associated with and experienced by participants. Findings are discussed in the context of harm reduction, public policy, and future inquiry into psychedelic substances for health applications.
Citations in the library
Cites 81
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study Journal of Psychopharmacology January 13, 2015
and 76 more in the library